Arrowhead Research (ARWR) Tops Q2 EPS by 4c, Beat on Revenue
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.00 +0.22%
Revenue Growth %: +89.5%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +89.5%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Arrowhead Research (NASDAQ: ARWR) reported Q2 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.99 million versus the consensus estimate of $5.51 million.
For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
- Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
